Tilray (TLRY) PT Lowered to $150 at Cowen
Tweet
Share
E-mail
Get Alerts TLRY Hot Sheet
Price: $1.84 --0%
Rating Summary:
4 Buy, 15 Hold, 5 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 11 | New: 14
Rating Summary:
4 Buy, 15 Hold, 5 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 11 | New: 14
Join SI Premium – FREE
Cowen analyst Vivien Azer lowered the price target on Tilray (NASDAQ: TLRY) to $150.00 (from $172.00) while maintaining a Outperform rating.
Azer commented, "While licensing delays caused TLRY's revenues to come in slightly lower than expected, underlying demand remains strong in both Canadian adult use and medical cannabis markets. We view this quarter, and likely 4Q18, as temporary speed bumps along the cannabis super highway."
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Jefferies Downgrades LTIMindtree Ltd (LTIM:IN) to Underperform
- TE Connectivity (TEL) PT Raised to $150 at Stifel
- KKR Real Estate Financial Trust (KREF) PT Lowered to $12 at JMP Securities
Create E-mail Alert Related Categories
Analyst Comments, Analyst EPS View, Analyst PT ChangeRelated Entities
Cowen & CoSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
